The neuronal ceroid-lipofuscinoses: From past to present

被引:173
|
作者
Haltia, Matti
机构
[1] Univ Helsinki, Dept Pathol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Helsinki 00014, Finland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2006年 / 1762卷 / 10期
关键词
neuronal ceroid lipofuscinoses; batten disease; lysosomal storage; molecular pathology; classification;
D O I
10.1016/j.bbadis.2006.06.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuronal ceroid-lipofuscinoses (NCLs) are inherited lysosomal storage diseases and constitute the most common group of children's progressive encephalopathies. Most childhood forms of NCL are clinically characterized by progressive loss of vision as well as mental and motor deterioration, epileptic seizures, and premature death, while the rare adult forms are dominated by dementia. All forms of NCL share common pathomorphological features. Autofluorescent, periodic acid-Schiff- and Sudan black B-positive granules, resistant to lipid solvents, accumulate in the cytoplasm of most nerve cells, and there is progressive and remarkably selective neuronal degeneration and loss. For a long time, the NCLs were grouped under the heading of the "amaurotic family idiocies" and conceived as lipidoses. However, in the late 1980ies and 1990ies the NCL storage cytosomes were shown to consist largely of two hydrophobic proteins: either subunit c of mitochondrial ATP synthase or sphingolipid activator proteins A and D. Since 1995 numerous mutations in at least seven different genes have been shown to underlie the multiple human and animal forms of NCL. This review discusses the historical evolution of the NCL concept and the impact of the recent biochemical and molecular genetic findings on our views on the classification and pathogenesis of these devastating brain disorders. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:850 / 856
页数:7
相关论文
共 50 条
  • [1] THE NEURONAL CEROID-LIPOFUSCINOSES
    Bennett, Michael J.
    Rakheja, Dinesh
    DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2013, 17 (3-4) : 254 - 259
  • [2] The neuronal ceroid-lipofuscinoses
    Haltia, M
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (01) : 1 - 13
  • [3] Brain lysosomal hydrolases in neuronal ceroid-lipofuscinoses
    Prasad, VVTS
    Pullarkat, RK
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1996, 29 (2-3) : 169 - 179
  • [4] CLASSIFICATION OF THE NEURONAL CEROID-LIPOFUSCINOSES - EXPANSION OF THE ATYPICAL FORMS
    DYKEN, P
    WISNIEWSKI, K
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 57 (02): : 150 - 154
  • [5] The new nosography of the neuronal ceroid-lipofuscinoses
    Goebel, HH
    ANNALES DE PATHOLOGIE, 2000, 20 (05) : 479 - 491
  • [6] The neuronal ceroid-lipofuscinoses: A historical introduction
    Haltia, Matti
    Goebel, Hans H.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (11): : 1795 - 1800
  • [7] Leukocytes in neuronal ceroid-lipofuscinoses: Function and apoptosis
    Kieseier, BC
    Wisniewski, KE
    Park, E
    SchullerLevis, G
    Mehta, PD
    Goebel, HH
    BRAIN & DEVELOPMENT, 1997, 19 (05) : 317 - 322
  • [8] PRENATAL ULTRASTRUCTURAL DIAGNOSIS IN THE NEURONAL CEROID-LIPOFUSCINOSES
    GOEBEL, HH
    PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (07) : 728 - 733
  • [9] NEURONAL CEROID-LIPOFUSCINOSES IN ITALY - AN EPIDEMIOLOGIC-STUDY
    CARDONA, F
    ROSATI, E
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 57 (02): : 142 - 143
  • [10] Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease)
    Jolly, RD
    Brown, S
    Das, AM
    Walkley, SU
    NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (06) : 565 - 571